Potential Use of Cellular Stromal Vascular Fraction In Post-COVID-19 Pulmonary Injury and Adult Respiratory Distress Syndrome: Overview of COVID-19 Lung …
RW Alexander - Journal of Current Medical Research and Opinion, 2020 - cmro.in
Abstract A coronavirus (nCoV-2) has caused a worldwide pandemic, beginning in Wuhan,
China. Patient's acquiring viral infection (COVID-19) which is often featured by elevation of …
China. Patient's acquiring viral infection (COVID-19) which is often featured by elevation of …
[PDF][PDF] Overview of COVID-19 lung damage clinical trial using Cellular Stromal Vascular Fraction (CSVF) and Functional Respiratory Imaging (FRI) analysis of …
RW Alexander - Ann. Stem Cell Res. Ther, 2020 - nkjinstitute.com
Abstract A coronavirus (nCoV-2) has caused a worldwide pandemic, beginning in Wuhan,
China. Patient's acquiring viral infection (COVID-19) which is featured by elevation of …
China. Patient's acquiring viral infection (COVID-19) which is featured by elevation of …
Therapeutic potential of the stromal vascular fraction in COVID-19
VN Pavlov, AA Kazikhinurov… - HERALD of North …, 2021 - journals.eco-vector.com
The new coronavirus infection (COVID-19) is already known to cause serious respiratory
illnesses such as pneumonia and lung failure. COVID-19 has caused catastrophic damage …
illnesses such as pneumonia and lung failure. COVID-19 has caused catastrophic damage …
[HTML][HTML] Adipose stem cells (ASCs) and stromal vascular fraction (SVF) as a potential therapy in combating (COVID-19)-disease
P Gentile, A Sterodimas - Aging and disease, 2020 - ncbi.nlm.nih.gov
A recent and interesting study reported improved respiratory activity after intravenous
administration of mesenchymal stem cells (MSCs) into patients affected by coronavirus …
administration of mesenchymal stem cells (MSCs) into patients affected by coronavirus …
[HTML][HTML] Adipose-derived stromal vascular fraction cells to treat long-term pulmonary sequelae of coronavirus disease 2019: 12-month follow-up
M Carstens, J Trujillo, Y Dolmus, C Rivera… - Cytotherapy, 2024 - Elsevier
Background aims Long coronavirus disease (COVID) is estimated to occur in up to 20% of
patients with coronavirus disease 2019 (COVID-19) infections, with many having persistent …
patients with coronavirus disease 2019 (COVID-19) infections, with many having persistent …
Total Stromal Fraction (TSF)-Fortified Adipose Tissue-Derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary …
M Jeyaraman, S Muthu, R Jain, AS Satish… - …, 2022 - ingentaconnect.com
The inception of the COVID-19 pandemic has jeopardized humanity with markedly
dampening of worldwide resources. The viral infection may present with varying signs and …
dampening of worldwide resources. The viral infection may present with varying signs and …
[HTML][HTML] Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 associated pulmonary diseases: From bench to bedside
LS Zhang, Y Yu, H Yu, ZC Han - World Journal of Stem Cells, 2021 - ncbi.nlm.nih.gov
The ongoing outbreak of coronavirus disease 2019 (COVID-19) caused by the novel severe
acute respiratory syndrome coronavirus 2 has become a sudden public emergency of …
acute respiratory syndrome coronavirus 2 has become a sudden public emergency of …
Post-COVID-19 pulmonary fibrosis: the rationale of mesenchymal stem cell transplantation for lung regeneration
NNQ Dinh, NB Vu, P Van Pham - Biomedical Research and Therapy, 2022 - bmrat.com
Abstract Coronavirus disease 2019 (COVID-19) has caused nearly 15 million deaths
worldwide. The rapid development of COVID-19 vaccines and anti-viral drugs significantly …
worldwide. The rapid development of COVID-19 vaccines and anti-viral drugs significantly …
Mesenchymal stromal cells and pleiotropic therapeutic advantages in COVID-19 management
VK Singh, UKS Vaksh, P Sharma - Stem Cells, 2024 - Elsevier
The pandemic burst of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or
coronavirus disease 2019 (COVID-19) infections shattered existing medical and research …
coronavirus disease 2019 (COVID-19) infections shattered existing medical and research …
Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosis
G Gazzaniga, M Voltini, A Carletti, E Lenta… - Respiratory …, 2024 - Springer
While the COVID-19 outbreak and its complications are still under investigation, post-
inflammatory pulmonary fibrosis (PF) has already been described as a long-term sequela of …
inflammatory pulmonary fibrosis (PF) has already been described as a long-term sequela of …
相关搜索
- pulmonary injury lung damage
- pulmonary vasculature covid 19
- therapeutic potential covid 19
- stem cells covid 19
- pulmonary fibrosis lung regeneration
- neutrophil activity covid 19
- matrix remodeling covid 19
- wound healing covid 19
- therapeutic potential sars cov
- stem cells sars cov
- stem cells therapeutic potential
- pulmonary diseases covid 19
- pulmonary fibrosis covid 19
- therapeutic prospects covid 19